Products

Refine

Country

Business Type

Certificate

Display

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

We can provide GMP validation service that complies with SFDA, FDA, WHO and EU EMPA.Excellent registration team could help us easlily to register our products in different countries.If you and your customer are interested in some products or need CMO

Cyclo (-RGDfK) manufacturer/supplier

Cas:161552-03-0

Min.Order:1 Gram

Negotiable

Type:Manufacturers

inquiry

Xi'an Xszo Chem Co., Ltd.

1. Factory price and high quality must be guaranteed, base on 8 years of production and R&D experience2. Free samples will be provided,ensure specifications and quality are right for customer3. Customers will receive the most professional technical s

Factory Price API 99% CYCLO (ARG-GLY-ASP-D-PHE-LYS) 161552-03-0 GMP Manufacturer

Cas:161552-03-0

Min.Order:1 Gram

FOB Price: $0.1

Type:Manufacturers

inquiry

Shanghai Seasonsgreen Chemical Co.,Ltd

Shanghai Seasonsgreen Chemical is a high-tech research and development, production, sale and custom synthesis set in one high-tech chemical products enterprises. Our sales and marketing division is located in Shanghai, serving international pharmaceu

lower price High quality CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Kilogram

FOB Price: $1.0

Type:Manufacturers

inquiry

Hebei yanxi chemical co.,LTD.

Hebei yanxi chemical co., LTD is a professional research, development and production Cyromazine、lead diacetate trihydrate /Lead acetate trihydrateC、 2-phenylacetamide 、 4-Aminophenyl-1-phenethylpiperidine 、Citric acid monohydrate 、 Citric acid/c

161552-03-0 CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Kilogram

FOB Price: $2.0

Type:Trading Company

inquiry

Dayang Chem (Hangzhou) Co.,Ltd.

As a leading manufacturer and supplier of chemicals in China, DayangChem not only supply popular chemicals, but also DayangChem’s R&D center offer custom synthesis according to the contract research and development services for the fine chemicals, ph

Cyclo(-Arg-Gly-Asp-D-Phe-Lys)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Lab/Research institutions

inquiry

Shanghai Upbio Tech Co.,Ltd

1.No Less 8 years exporting experience. Clients can 100% received goods 2.Lower Price with higher quality 3,Free sample 4,We are sincerely responsible for the "product quality" and "After Service" Upbio is Specialized

CYCLO (ARG-GLY-ASP-D-PHE-LYS) 161552-03-0

Cas:161552-03-0

Min.Order:1 Kilogram

Negotiable

Type:Lab/Research institutions

inquiry

Qingdao Beluga Import and Export Co., LTD

CYCLO (ARG-GLY-ASP-D-PHE-LYS) CAS:161552-03-0 Qingdao Belugas Import and Export Co., Ltd. is a scientific and technological company integrating research and development, production and trade of chemical intermediates, specializing in high quality or

CYCLO (ARG-GLY-ASP-D-PHE-LYS) CAS:161552-03-0

Cas:161552-03-0

Min.Order:1 Gram

Negotiable

Type:Lab/Research institutions

inquiry

Shandong Hanjiang Chemical Co., Ltd.

Hello, dear friend! I'm Hansen and Allen from China. Welcome to my lookchem mall! The following is a brief introduction of our company's products and services. If you are interested in our products, please contact us by emai

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Kilogram

Negotiable

Type:Lab/Research institutions

inquiry

Henan Wentao Chemical Product Co., Ltd.

Henan Wentao Chemical Product Co.,Ltd is Located in Zhengzhou High-tech Development Zone with import and export license, We passed ISO 9001:2008 as well, Henan Wentao has developed more than 1000 compounds, which are widely used in the fields of prod

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Lab/Research institutions

inquiry

Zibo Hangyu Biotechnology Development Co., Ltd

Zibo Hangyu Biotechnology Development Co., Ltd is a leading manufacturer and supplier of chemicals in China. We develop produce and distribute high quality pharmaceuticals, intermediates, special chemicals and OLED intermediates and other fine chemi

c(RGDfK)

Cas:161552-03-0

Min.Order:10 Gram

FOB Price: $100.0

Type:Lab/Research institutions

inquiry

TaiChem Taizhou Limited

Established in May 2015, TaiChem Ltd. is initially invested by a British research and development company and started by PhDs back from aboard. The company is registered in China Medical City (CMC), Taizhou, Jiangsu Province, and the production site

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:10 Gram

Negotiable

Type:Lab/Research institutions

inquiry

Henan Tianfu Chemical Co., Ltd.

CYCLO (ARG-GLY-ASP-D-PHE-LYS) Basic information Product Name: CYCLO (ARG-GLY-ASP-D-PHE-LYS) Synonyms: CYCLO(-RGDFK);CYCLO (ARG-GLY-ASP-D-PHE-LYS);cyclo (Arg-Gly-Asp-Phe-Lys);c(RGDfK);Cyc

TIANFU-CHEM CAS:161552-03-0 CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Gram

Negotiable

Type:Lab/Research institutions

inquiry

Zibo Dorne chemical technology co. LTD

Product Details Grade: pharmaceutical grade Purity:99%+ ProductionCapacity: 1000 Kilogram/Month Scope of use: For scientific research only(The product must be used legally) Our Advantage 1. Best quality with competitive price. 2. Quick shipping,

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Kilogram

Negotiable

Type:Lab/Research institutions

inquiry

Xiamen Jenny Chemical Technology Co., Ltd.

GMP standard, high purity, competitive price, in stock 1. Quick Response: within 6 hours after receiving your email. 2. Quality Guarantee: All products are strictly tested by our QC, confirmed by QA, and approved by a third-party lab in China, USA,

CYCLO(ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:1 Milligram

Negotiable

Type:Trading Company

inquiry

EAST CHEMSOURCES LIMITED

factory?direct?saleAppearance:White Powder Storage:Store In Dry, Cool And Ventilated Place Package:25kg/drum, also according to the clients requirement Application:It is widely used as a thickener, emulsifier and stabilizer Transportation:By Sea Or B

cyclo (Arg-Gly-Asp-Phe-Lys)

Cas:161552-03-0

Min.Order:1 Kilogram

FOB Price: $18.0 / 20.0

Type:Trading Company

inquiry

Shandong Mopai Biotechnology Co., LTD

Shandong Mopai Biotechnology Co., LTD is a leading manufacturer and supplier of chemicals in China. We develop produce and distribute high quality pharmaceuticals, intermediates, special chemicals and OLED intermediates and other fine chemicals. W

cyclo (Arg-Gly-Asp-Phe-Lys)

Cas:161552-03-0

Min.Order:1 Gram

Negotiable

Type:Lab/Research institutions

inquiry

KAISA GROUP INC

1.Applied in food field.it can improve the immune system and prolong life. 2.Appliedin cosmetic field.it can improve the skin care. 3.Applied in pharmaceutical field.it can treat various dieases. 4.Our product quality assurance will make our customer

cyclo (Arg-Gly-Asp-Phe-Lys)

Cas:161552-03-0

Min.Order:1 Metric Ton

FOB Price: $1.5

Type:Trading Company

inquiry

Suzhou Health Chemicals Co., Ltd.

High quality,stable supply chain.Appearance:white/off-white or light yellow Storage:Store in cool and dry place, keep away from strong light and heat. Package:aluminum bottle,glass bottle,PTFE bottle,cardboard drum Application:This product can be use

Cyclic RGDFK peptide

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Lab/Research institutions

inquiry

Bluecrystal chem-union

We are a Union of chemistry in China, consists of chemists,engineers, laboratories,factories in China. We organize surplus capacity of R&D and production as well as custom synthesis for chemical products and chemical business project. We are supp

cyclo (Arg-Gly-Asp-Phe-Lys)

Cas:161552-03-0

Min.Order:1 Metric Ton

FOB Price: $1.0

Type:Trading Company

inquiry

Hebei Mojin Biotechnology Co.,Ltd

1, High quality with competitive price:2, Fast and safe delivery3.Excellent pre-sales and after-sales service4. Well-trained and professional technologist and sales with rich experience in the field for 5-10 yearsAppearance:see detailed specification

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Trading Company

inquiry

Sinoway Industrial Co., Ltd.

Why is SINOWAY:1) Specialized in pharmaceutical and healthcare industrial since 19872) ISO 9001:2015 & SGS audited supplier . 3) Accept various payment terms : T.T 30-60 days.4) We have warehouse in USA with quickly shipment .5) We can do different t

99% up by HPLC CYCLO (ARG-GLY-ASP-D-PHE-LYS) 161552-03-0

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Trading Company

inquiry

Hangzhou Dingyan Chem Co., Ltd

R & D enterprises have their own stock in stock Package:1kg Application:pharmaceutical intermediates

c(RGDfK)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Manufacturers

inquiry

Shanghai Acmec Biochemical Technology Co., Ltd.

Acmec is a leading manufacturer and supplier of biochemical reagents and life science products. We have over 40,000 items in stock (real-time inventory) and offer discounted prices to registered members of the online store ( www.acmec.com.cn ) Appea

Acmec Cyclo(-Arg-Gly-Asp-D-Phe-Lys) 25mg

Cas:161552-03-0

Min.Order:1 bottle

Negotiable

Type:Lab/Research institutions

inquiry

Hangzhou J&H Chemical Co., Ltd.

J&H CHEM is one of China's leading providers of integrated fine chemical services including offering, research and development, Custom manufacturing business, as well as other Value-added customer services, for diversified range products of chemicals

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Lab/Research institutions

inquiry

Xian Changyue Biological Technology Co., Ltd.

best seller Application:API

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Manufacturers

inquiry

BOC Sciences

BOC Sciences is committed to supplying cost-effective products and services. We provide Cyclo (-RGDfK). Cyclo (-RGDfK) is a potent and selective αvβ3 integrin inhibitor.More information please visit:www.bocsci.com/cyclo-rgdfk-cas-161552-

Cyclo (-RGDfK)

Cas:161552-03-0

Min.Order:1 Gram

Negotiable

Type:Trading Company

inquiry

Hebei Sankai Chemical Technology Co., Ltd

1. Product advantages? High purity, all above 98.5%, no impurities after dissolution? We will test each batch to ensure quality? OEM and private brand services designed for free? Various cap colors available? We can also provide MT1 peptide powder2.

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Trading Company

inquiry

Antimex Chemical Limied

Ansciep Chemical is a professional enterprise manufacturing and distributing fine chemicals and speciality chemicals. We have been dedicated to heterocycle compounds and phenyl rings for tens of years. This is our mature product for export. Our quali

CYCLO (ARG-GLY-ASP-D-PHE-LYS)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Lab/Research institutions

inquiry

Hubei Langyou International Trading Co., Ltd

cyclo (Arg-Gly-Asp-Phe-Lys) Application:cyclo (Arg-Gly-Asp-Phe-Lys)

cyclo (Arg-Gly-Asp-Phe-Lys)

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Other

inquiry

Guangdong Juda Chemical Industrial Co.,Limited

Factory supply high purity low priceAppearance:solid or liquid Storage:sealed in cool and dry place Package:As customer's requested Application:Pharma Intermediate Transportation:by courier/air/sea Port:Any port in China

Cyclic RGDFK peptide CAS No.161552-03-0

Cas:161552-03-0

Min.Order:0

Negotiable

Type:Trading Company

inquiry

Synthetic route

C42H51ClN10O11

C42H51ClN10O11

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol; acetic acid at 20℃; for 18h;100%
Fmoc-Asp(OAll)-Pol

Fmoc-Asp(OAll)-Pol

N-(fluoren-9-ylmethoxycarbonyl)glycine
29022-11-5

N-(fluoren-9-ylmethoxycarbonyl)glycine

Fmoc-Lys(tert-butoxycarbonyl)
71989-26-9

Fmoc-Lys(tert-butoxycarbonyl)

Fmoc-D-Phe-OH
86123-10-6

Fmoc-D-Phe-OH

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Stage #1: Fmoc-Asp(OAll)-Pol
Stage #2: N-(fluoren-9-ylmethoxycarbonyl)glycine
Stage #3: Fmoc-Lys(tert-butoxycarbonyl); Fmoc-D-Phe-OH; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages;
43%
2-chlorotrityl resin

2-chlorotrityl resin

Fmoc-dPhe-OH

Fmoc-dPhe-OH

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Nα-Fmoc-Nε-Trt-Lys
111061-54-2

Nα-Fmoc-Nε-Trt-Lys

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Stage #1: H-Gly-(2-Cl)-Trt-pol; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine With N-ethyl-N,N-diisopropylamine; [ethyl cyano(hydroxyimino)acetato-O2]tri-1-pyrrolidinylphosphonium hexafluorophosphate at 20℃; for 1h; 2-CT Cl resin;
Stage #2: With piperidine In N,N-dimethyl-formamide at 20℃; for 0.1h;
Stage #3: Fmoc-dPhe-OH; Fmoc-(tBu)Asp-OH; Nα-Fmoc-Nε-Trt-Lys Further stages;
43%
2-chlorotrityl resin

2-chlorotrityl resin

Fmoc-dPhe-OH

Fmoc-dPhe-OH

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Lys(OAc)-OH
159766-56-0

Fmoc-Lys(OAc)-OH

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Stage #1: H-Gly-(2-Cl)-Trt-pol; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine With N-ethyl-N,N-diisopropylamine; [ethyl cyano(hydroxyimino)acetato-O2]tri-1-pyrrolidinylphosphonium hexafluorophosphate at 20℃; for 1h; 2-CT Cl resin;
Stage #2: With piperidine In N,N-dimethyl-formamide at 20℃; for 0.1h;
Stage #3: Fmoc-dPhe-OH; Fmoc-(tBu)Asp-OH; Fmoc-Lys(OAc)-OH Further stages;
43%
C45H67N9O10S
388633-54-3

C45H67N9O10S

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With chlorotriisopropylsilane; water; trifluoroacetic acid for 2h;
Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-D-Phe-OH
86123-10-6

Fmoc-D-Phe-OH

Alloc-L-Lys(N-Fmoc)-OH
186350-56-1

Alloc-L-Lys(N-Fmoc)-OH

R(Pmc)-G linear peptide bound to resin

R(Pmc)-G linear peptide bound to resin

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multistep reaction;
Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Asn-OHFmoc-Leu-OH

Fmoc-Asn-OHFmoc-Leu-OH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Pd(PPh3)4; PhSiH3
2: TFA; triisopropylsilane; water / 2 h
View Scheme
Fmoc-D-Phe-OH
86123-10-6

Fmoc-D-Phe-OH

bis-1,4-aminomethylcyclohexane on chlorotrityl resin

bis-1,4-aminomethylcyclohexane on chlorotrityl resin

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Pd(PPh3)4; PhSiH3
2: TFA; triisopropylsilane; water / 2 h
View Scheme
(S)-6-allyloxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid
146982-27-6

(S)-6-allyloxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Pd(PPh3)4; PhSiH3
2: TFA; triisopropylsilane; water / 2 h
View Scheme
cyclo(-D(tBu)-f-K(Aloc)-R(Pmc)-G-)
343312-39-0

cyclo(-D(tBu)-f-K(Aloc)-R(Pmc)-G-)

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Pd(PPh3)4; PhSiH3
2: TFA; triisopropylsilane; water / 2 h
View Scheme
C39H56N10O11
1035105-00-0

C39H56N10O11

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
for 2h; UV-irradiation;
C74H84N9O12PolS

C74H84N9O12PolS

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With chlorotriisopropylsilane; trifluoroacetic acid In dichloromethane at 20℃; for 3h; solid phase reaction;0.45 mg
C39H56N10O11
1035105-00-0

C39H56N10O11

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
for 1.5h; Irradiation;92 %Chromat.
N-(fluoren-9-ylmethoxycarbonyl)glycine
29022-11-5

N-(fluoren-9-ylmethoxycarbonyl)glycine

Fmoc-Lys(tert-butoxycarbonyl)
71989-26-9

Fmoc-Lys(tert-butoxycarbonyl)

Fmoc-D-Phe-OH
86123-10-6

Fmoc-D-Phe-OH

N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester
146982-24-3

N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Stage #1: N-alpha-(9-fluorenylmethyloxycarbonyl)-L-aspartic acid beta-allyl ester With N-ethyl-N,N-diisopropylamine In dichloromethane for 3h; 2-chlorotrityl chloride polystyrene resin;
Stage #2: With piperidine In 1-methyl-pyrrolidin-2-one for 0.416667h;
Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Lys(tert-butoxycarbonyl); Fmoc-D-Phe-OH; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages;
c[R]GDfK

c[R]GDfK

A

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one
54711-38-5

7-(diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one

B

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With water In aq. buffer pH=7.4; Irradiation;
C21H29BrN8O8

C21H29BrN8O8

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: dichloromethane / 20 °C
2.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
2.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
3.1: hydrogenchloride / 1,4-dioxane / 20 °C
4.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
4.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
5.1: hydrogenchloride / 1,4-dioxane / 20 °C
6.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
6.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
7.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
8.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
9.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C16H21BrN8O6*C2HF3O2

C16H21BrN8O6*C2HF3O2

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
1.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
2.1: hydrogenchloride / 1,4-dioxane / 20 °C
3.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
3.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
4.1: hydrogenchloride / 1,4-dioxane / 20 °C
5.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
5.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
6.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
7.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
8.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C35H46BrClN10O11

C35H46BrClN10O11

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: hydrogenchloride / 1,4-dioxane / 20 °C
2.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
2.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
3.1: hydrogenchloride / 1,4-dioxane / 20 °C
4.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
4.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
5.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
6.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
7.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C30H38BrClN10O9*ClH

C30H38BrClN10O9*ClH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
1.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
2.1: hydrogenchloride / 1,4-dioxane / 20 °C
3.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
3.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
4.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
5.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
6.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C44H55BrClN11O12

C44H55BrClN11O12

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: hydrogenchloride / 1,4-dioxane / 20 °C
2.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
2.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
3.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
4.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
5.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C39H47BrClN11O10*ClH

C39H47BrClN11O10*ClH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: N-ethyl-N,N-diisopropylamine; bis(trichloromethyl) carbonate / N,N-dimethyl-formamide; acetonitrile / 0 h / 20 °C / Flow reactor
1.2: 0 h / 20 °C / pH 8 - 9 / Flow reactor
2.1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
3.1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
4.1: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C55H66BrClN12O15

C55H66BrClN12O15

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / 1,4-dioxane / 0.67 h / 20 °C
2: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
3: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
C50H58BrClN12O13

C50H58BrClN12O13

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetonitrile / 0.08 h / 20 °C / UV-irradiation; Flow reactor
2: hydrogen; palladium 10% on activated carbon / methanol; acetic acid / 18 h / 20 °C
View Scheme
Fmoc-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH

Fmoc-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: piperidine / N,N-dimethyl-formamide / 3 h / 0 - 20 °C
2: sodium hydroxide; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol / N,N-dimethyl-formamide / 24 h / 20 °C / pH 8
3: trifluoroacetic acid; methyl-phenyl-thioether; chlorotriisopropylsilane; phenol / 3 h / 20 °C
View Scheme
H-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH
942132-29-8

H-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; benzotriazol-1-ol / N,N-dimethyl-formamide / 24 h / 20 °C / pH 8
2: trifluoroacetic acid; methyl-phenyl-thioether; chlorotriisopropylsilane; phenol / 3 h / 20 °C
View Scheme
cyclized H2N-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH
545376-68-9

cyclized H2N-Asp(OtBu)-D-Phe-Lys(Boc)-Arg(Pbf)-Gly-OH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With chlorotriisopropylsilane; methyl-phenyl-thioether; trifluoroacetic acid; phenol at 20℃; for 3h;
With chlorotriisopropylsilane; water; trifluoroacetic acid at 20℃; for 24h;
Gly-Arg(Pbf)-Lys(Boc)-D-Phe-Asp(OtBu)-OH

Gly-Arg(Pbf)-Lys(Boc)-D-Phe-Asp(OtBu)-OH

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate; diphenyl phosphoryl azide / N,N-dimethyl-formamide / 24 h / 20 °C
2: trifluoroacetic acid; water; chlorotriisopropylsilane / 24 h / 20 °C
View Scheme
C45H67N9O13S

C45H67N9O13S

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate; diphenyl phosphoryl azide / N,N-dimethyl-formamide
2: trifluoroacetic acid; chlorotriisopropylsilane / water / 2 h / 20 °C
View Scheme
C45H65N9O12S

C45H65N9O12S

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
With chlorotriisopropylsilane; trifluoroacetic acid In water at 20℃; for 2h;
C56H67ClN11O8Pol

C56H67ClN11O8Pol

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Conditions
ConditionsYield
Stage #1: C56H67ClN11O8Pol With hydrazine hydrate In N,N-dimethyl-formamide for 0.0833333h; CTC-resin;
Stage #2: With methyl-phenyl-thioether; ethane-1,2-dithiol; methoxybenzene; trifluoroacetic acid CTC-resin;
C14H21N5O7
1145938-00-6

C14H21N5O7

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C37H57N13O11
1145938-02-8

C37H57N13O11

Conditions
ConditionsYield
In dimethyl sulfoxide; acetonitrile99%
ADIBO-PEG5-N-succinimidyl ester
1378531-80-6

ADIBO-PEG5-N-succinimidyl ester

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C59H79N11O15
1415001-59-0

C59H79N11O15

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide at 20℃;90%
C26H39NO13
1422540-83-7

C26H39NO13

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C47H75N9O17
1422541-06-7

C47H75N9O17

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 15h; Inert atmosphere;86%
1,3-bis[4, 10-bis(carboxymethyl)-1,4,10-triaza-7-oxacyclododec-1-ylmethyl]-5-isothiocyanatobenzene hydrochloride salt

1,3-bis[4, 10-bis(carboxymethyl)-1,4,10-triaza-7-oxacyclododec-1-ylmethyl]-5-isothiocyanatobenzene hydrochloride salt

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C60H92N16O17S

C60H92N16O17S

Conditions
ConditionsYield
In aq. buffer at 20℃; for 24h; pH=9;84%
2,5-dioxopyrrolidin-1-yl (E)-3-(2-(2-(4-(dicyanomethylene)-6-methyl-4H-pyran-2-yl)vinyl)-7-(diphenylamino)-9-(2-(2-ethoxyethoxy)ethyl)-9H-fluoren-9-yl)propanoate

2,5-dioxopyrrolidin-1-yl (E)-3-(2-(2-(4-(dicyanomethylene)-6-methyl-4H-pyran-2-yl)vinyl)-7-(diphenylamino)-9-(2-(2-ethoxyethoxy)ethyl)-9H-fluoren-9-yl)propanoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C72H80N12O11

C72H80N12O11

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 24h; Inert atmosphere;82%
6-[(2-ethylcarbamothioyl)hydrazinyl]-3-pyridinecarboxylic acid

6-[(2-ethylcarbamothioyl)hydrazinyl]-3-pyridinecarboxylic acid

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C36H51N13O8S

C36H51N13O8S

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;80%
C52H50N12O10Si

C52H50N12O10Si

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C79H89N21O16Si

C79H89N21O16Si

Conditions
ConditionsYield
Stage #1: C52H50N12O10Si With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 4h;
Stage #2: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
78%
cholesterol-tetraethylene glycol-DSC

cholesterol-tetraethylene glycol-DSC

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

cholesterol-cRGDfK

cholesterol-cRGDfK

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 16h;74%
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 16h;74%
2,5-dioxopyrrolidin-1-yl pent-4-ynoate
132178-37-1

2,5-dioxopyrrolidin-1-yl pent-4-ynoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-N6-pent-4-ynoyl-L-lysyl)
1076242-17-5

cyclo(L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-N6-pent-4-ynoyl-L-lysyl)

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide70%
[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

Chloroacetic anhydride
541-88-8

Chloroacetic anhydride

cyclo[Lys(ClAc)-Arg-Gly-Asp-D-Phe]

cyclo[Lys(ClAc)-Arg-Gly-Asp-D-Phe]

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 10h;65%
6-maleimidohexanoic acid N-hydroxylsuccinimide ester
55750-63-5

6-maleimidohexanoic acid N-hydroxylsuccinimide ester

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C37H52N10O10

C37H52N10O10

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 4h;64.1%
C48H60N5O8S(1+)*I(1-)*Na(1+)

C48H60N5O8S(1+)*I(1-)*Na(1+)

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C75H99N14O14S(1+)*I(1-)*Na(1+)

C75H99N14O14S(1+)*I(1-)*Na(1+)

Conditions
ConditionsYield
Stage #1: C48H60N5O8S(1+)*I(1-)*Na(1+) With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 0.5h; Inert atmosphere;
Stage #2: With O-(N-succinimidyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate In N,N-dimethyl-formamide for 3h; Inert atmosphere;
Stage #3: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 18h;
60%
2,5-dioxopyrrolidin-1-yl 3-iodobenzoate
91487-18-2

2,5-dioxopyrrolidin-1-yl 3-iodobenzoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C34H44IN9O8

C34H44IN9O8

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 3h;59%
C18H18N6O5

C18H18N6O5

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C41H54N14O9

C41H54N14O9

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 0.5h;57%
succinimidyl 4-formylbenzoate
60444-78-2

succinimidyl 4-formylbenzoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C35H45N9O9
1261036-91-2

C35H45N9O9

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 1h; pH=7.5; aq. phosphate buffer;56%
6-[2-(phenylcarbamothioyl)hydrazinyl]-3-pyridinecarboxylic acid

6-[2-(phenylcarbamothioyl)hydrazinyl]-3-pyridinecarboxylic acid

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C40H51N13O8S

C40H51N13O8S

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;55%
rel-(1R-4E-pS)-cyclooct-4-ene-1-yl (4-nitrophenyl) carbonate

rel-(1R-4E-pS)-cyclooct-4-ene-1-yl (4-nitrophenyl) carbonate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C36H53N9O9

C36H53N9O9

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 6h;52%
C42H48N6O10Pd

C42H48N6O10Pd

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

palladium 31-oxo-15-methoxycarbonylmethyl-rhodobacteriochlorin 131-(2,3-dihydroxypropyl)amide-173-(cycloRGDfK)amide

palladium 31-oxo-15-methoxycarbonylmethyl-rhodobacteriochlorin 131-(2,3-dihydroxypropyl)amide-173-(cycloRGDfK)amide

Conditions
ConditionsYield
With triethylamine In 1-methyl-pyrrolidin-2-one for 1.25h;50%
2,5-dioxopyrrolidin-1-yl-6-(4-(dimethylamino)phenoxy)hexanoate
1338496-56-2

2,5-dioxopyrrolidin-1-yl-6-(4-(dimethylamino)phenoxy)hexanoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C41H60N10O9
1338496-53-9

C41H60N10O9

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃;50%
[Ru(2,2′:6′,2″-terpyridine)(2,2′-bipyridine)(D-biotin)](Cl)2

[Ru(2,2′:6′,2″-terpyridine)(2,2′-bipyridine)(D-biotin)](Cl)2

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C62H74N16O9RuS(2+)*2Cl(1-)

C62H74N16O9RuS(2+)*2Cl(1-)

Conditions
ConditionsYield
Stage #1: [Ru(2,2′:6′,2″-terpyridine)(2,2′-bipyridine)(D-biotin)](Cl)2 With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-hydroxy-2,5-dioxopyrrolidine-3-sulfonic acid In dimethyl sulfoxide at 20℃; for 24h; Darkness;
Stage #2: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With triethylamine pH=7; Darkness;
50%
11-azido-3,6,9-trioxaundecanoic acid
172531-37-2

11-azido-3,6,9-trioxaundecanoic acid

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

2-((2S,5R,8S,11S)-8-(1-azido-11-oxo-3,6,9-trioxa-12-azahexadecan-16-yl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid

2-((2S,5R,8S,11S)-8-(1-azido-11-oxo-3,6,9-trioxa-12-azahexadecan-16-yl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid

Conditions
ConditionsYield
Stage #1: 11-azido-3,6,9-trioxaundecanoic acid With 1-hydroxy-pyrrolidine-2,5-dione; dicyclohexyl-carbodiimide In dimethyl sulfoxide at 20℃;
Stage #2: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid In dimethyl sulfoxide at 20℃;
48.3%
[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

(3R,4R,5R,6S)-6-((((9H-fluoren-9-yl)methoxy)carbonylamino)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
655246-28-9

(3R,4R,5R,6S)-6-((((9H-fluoren-9-yl)methoxy)carbonylamino)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

C49H62N10O14

C49H62N10O14

Conditions
ConditionsYield
Stage #1: (3R,4R,5R,6S)-6-((((9H-fluoren-9-yl)methoxy)carbonylamino)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid With 1-hydroxy-pyrrolidine-2,5-dione; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 6h;
43%
5,5′,5″-(((1,4,7-triazonane-1,4,7-triyl)tris(methylene))tris(1H-imidazole-2,1-diyl))tripentanoic acid

5,5′,5″-(((1,4,7-triazonane-1,4,7-triyl)tris(methylene))tris(1H-imidazole-2,1-diyl))tripentanoic acid

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C114H168N36O24

C114H168N36O24

Conditions
ConditionsYield
Stage #1: 5,5′,5″-(((1,4,7-triazonane-1,4,7-triyl)tris(methylene))tris(1H-imidazole-2,1-diyl))tripentanoic acid With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid In N,N-dimethyl-formamide for 2h;
41%
C16H22Cl2N4O12Pt
1542144-06-8

C16H22Cl2N4O12Pt

C54H61N9O11Si

C54H61N9O11Si

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C89H114Cl2N20O24PtSi

C89H114Cl2N20O24PtSi

Conditions
ConditionsYield
Stage #1: C54H61N9O11Si; [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With N-ethyl-N,N-diisopropylamine In dimethyl sulfoxide at 20℃; for 0.166667h;
Stage #2: C16H22Cl2N4O12Pt In dimethyl sulfoxide at 20℃; for 24h;
40%
C49H49N3O10S2*2H3N

C49H49N3O10S2*2H3N

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C72H85N11O14S2

C72H85N11O14S2

Conditions
ConditionsYield
Stage #1: [(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 0.00833333h;
Stage #2: C49H49N3O10S2*2H3N In N,N-dimethyl-formamide at 20℃; for 2h; Inert atmosphere;
36%
N-succinimidyl 3-bromobenzoate

N-succinimidyl 3-bromobenzoate

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid
161552-03-0

[(2S,5R,8S,11S)-8-(4-Amino-butyl)-5-benzyl-11-(3-guanidino-propyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid

C34H44BrN9O8

C34H44BrN9O8

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 3h;35%

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View